Rep. Thomas H. Kean, Jr. Sells Waters Corporation (NYSE:WAT) Stock

Representative Thomas H. Kean, Jr. (Republican-New Jersey) recently sold shares of Waters Corporation (NYSE:WAT). In a filing disclosed on March 18th, the Representative disclosed that they had sold between $1,001 and $15,000 in Waters stock on February 13th.

Representative Thomas H. Kean, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Linde (NASDAQ:LIN) on 2/18/2026.
• Purchased $1,001 – $15,000 in shares of First Citizens BancShares (NASDAQ:FCNCA) on 2/5/2026.
• Sold $15,001 – $50,000 in shares of Alphabet (NASDAQ:GOOGL) on 2/5/2026.
• Purchased $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 1/29/2026.
• Sold $15,001 – $50,000 in shares of Stryker (NYSE:SYK) on 1/23/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/23/2026.
• Sold $15,001 – $50,000 in shares of Johnson & Johnson (NYSE:JNJ) on 1/23/2026.
• Sold $15,001 – $50,000 in shares of Markel Group (NYSE:MKL) on 1/23/2026.
• Sold $1,001 – $15,000 in shares of General Motors (NYSE:GM) on 1/7/2026.

Waters Stock Up 1.1%

Waters stock opened at $302.29 on Tuesday. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $414.15. The firm has a market capitalization of $29.65 billion, a price-to-earnings ratio of 28.07, a price-to-earnings-growth ratio of 2.06 and a beta of 1.20. The stock’s fifty day moving average is $340.71 and its two-hundred day moving average is $351.56. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.27 and a current ratio of 1.73.

Waters (NYSE:WAT) last released its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share for the quarter, topping analysts’ consensus estimates of $4.50 by $0.03. Waters had a return on equity of 34.79% and a net margin of 20.30%.The company had revenue of $932.36 million during the quarter, compared to analysts’ expectations of $928.17 million. During the same period in the previous year, the firm posted $4.10 earnings per share. The business’s revenue for the quarter was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Analysts predict that Waters Corporation will post 12.86 EPS for the current fiscal year.

Institutional Trading of Waters

Several institutional investors have recently added to or reduced their stakes in the business. Brighton Jones LLC raised its stake in Waters by 112.9% during the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 673 shares in the last quarter. Integrated Wealth Concepts LLC increased its holdings in shares of Waters by 2.9% during the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after purchasing an additional 30 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Waters by 3.6% during the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after purchasing an additional 6,976 shares in the last quarter. Empowered Funds LLC lifted its holdings in Waters by 16.6% in the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after purchasing an additional 160 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in Waters in the second quarter worth about $232,000. Institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. William Blair began coverage on shares of Waters in a research note on Monday, January 5th. They issued an “outperform” rating for the company. Robert W. Baird set a $363.00 price objective on shares of Waters in a research report on Tuesday, February 10th. UBS Group dropped their target price on Waters from $395.00 to $370.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 10th. Guggenheim reiterated a “buy” rating and issued a $440.00 price target on shares of Waters in a research note on Tuesday, February 10th. Finally, Morgan Stanley reduced their price target on Waters from $423.00 to $350.00 and set an “equal weight” rating for the company in a report on Sunday, February 22nd. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $393.84.

Insider Activity

In other Waters news, Director Wei Jiang bought 500 shares of the company’s stock in a transaction that occurred on Monday, March 16th. The shares were acquired at an average cost of $289.46 per share, for a total transaction of $144,730.00. Following the acquisition, the director directly owned 3,441 shares of the company’s stock, valued at $996,031.86. This trade represents a 17.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.82% of the company’s stock.

About Representative Kean

Thomas Kean Jr. (Republican Party) is a member of the U.S. House, representing New Jersey’s 7th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Kean (Republican Party) is running for re-election to the U.S. House to represent New Jersey’s 7th Congressional District. He declared candidacy for the 2026 election.

Thomas Kean Jr. lives in Westfield, New Jersey. Kean earned a master’s degree from the Tufts University Fletcher School of Law and Diplomacy. His career experience includes working with the Environmental Protection Agency during the George H.W. Bush administration and as an advisor to former U.S. Representative Bob Franks, a firefighter, and an emergency medical technician. Kean has served as the vice president of a fire department.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.